At issue: A model for academic/industry collaboration

Schizophrenia Bulletin

Volumn 30, Issue 4, 2004, Pages 997-1004

  Carpenter Jr , William T ^a,b   Koenig, James I ^a   Bilbe, Graeme ^c   Bischoff, Serge ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Academic industry; Collaboration; Conflict of interest; Public private science; Schizophrenia; Science partnerships

Indexed keywords

CONTRACT; HEALTH CARE FINANCING; HEALTH CARE INDUSTRY; INVESTMENT; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; UNIVERSITY;

EID: 16344364682     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a007148     Document Type: Review

References (22)

1. Agnew, B. Financial conflicts get more scrutiny in clinical trials. Science, 289:1266-1267, 2000a.
2. Agnew, B. "HHS Conference on Conflict of Interest in Clinical Research Will Raise a New Question: Should Research Universities Worry About Their Own Conflicts of Interest?" Washington Fax, July 20, 2000b; available at http://www.washingtonfax.com.
3. Angell, M. Is academic medicine for sale? New England Journal of Medicine, 342(20):1516-1518, 2000.
4. Appelgate, W.B.; Furberg, C.D.; Byington, R.P.; and Grimm, R., Jr. The Multicenter Isradipine Diuretic Atherosclerosis Study. JAMA, 276(10):785-791, 1996.
5. Blumenthal, D. Academic-industrial relationships in the life sciences. New England Journal of Medicine, 349(25):2452-2459, 2003.
6. Blumenthal, D.; Campbell, E.G.; Anderson, M.S.; Causino, N.; and Louis, K.S. Withholding research results in academic life science: Evidence from a national survey of faculty. JAMA, 277:1224-1228, 1997.
7. Bodenheimer, T. Uneasy alliance: Clinical investigators and the pharmaceutical industry. New England Journal of Medicine, 342(20):1539-1544, 2000.
8. Boyd, E.A., and Bero, L.A. Assessing faculty financial relationships with industry. A case study. JAMA, 284(17):2209-2214, 2000.
9. Carpenter, W.T., and Buchanan, R.W. Schizophrenia. New England Journal of Medicine, 330:681-690, 1994.
10. Cho, M.K.; Shohara, R.; Schissel, A.; and Rennie, D. Policies on faculty conflicts of interest at U.S. universities. JAMA, 284(17):2203-2208, 2000.
11. DeAngelis, C.D. Conflict of interest and the public trust. JAMA, 284(17):2237-2238, 2000.
12. Editorial. Is the university-industrial complex out of control? Nature, 409:119, 2001.
13. Holden, C. NEJM admits breaking its own tough rules. Science, 287:1573, 2000.
14. Korn, S. Conflicts of interest in biomedical research. JAMA, 284(17):2234-2237, 2000.
15. Larkin, M. Whose article is it anyway? Lancet, 354:136, 1999.
16. Lo, B.; Wolf, L.E.; and Berkeley, A. Conflict-of-interest policies for investigators in clinical trials. New England Journal of Medicine, 343:1616-1620, 2000.
17. Martin, J.B., and Kasper, D.L. In whose best interest? Breaching the academic-industrial wall. New England Journal of Medicine, 343:1646-1649, 2000.
18. McCrary, S.V.; Anderson, C.B.; Jakovljevic, J.; Khan, T.; McCullough, L.B.; Wray, N.P.; and Brody, B.A. A national survey of policies on disclosure of conflicts of interest in biomedical research. New England Journal of Medicine, 343:1621-1626, 2000.
19. Nadis, S. Med school to relax rules on business links? Nature, 403:818, 2000.
20. Rothman, D.J. Medical professionalism: Focusing on the real issues. New England Journal of Medicine, 342:1284-1286, 2000.
21. Waddington, J.L.; Youssef, H.A.; and Kinsella, A. Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenias. Psychological Medicine, 25:849-857, 1995.
22. Weatherall, D. Academia and industry: Increasingly uneasy bedfellows. Lancet, 355:1574, 2000.